The Therapeutic Goods Administration is experiencing system issues linked to global Microsoft outages. Some services may be disrupted and we may take longer to respond to email and phone contact during this time.
EVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector (2025-26)
Product name
EVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector
Sponsor name
Amgen Australia Pty Ltd
Year Range
2025-26